Cita APA

Matsumoto, Y., Kawaguchi, T., Yamamoto, N., Sawa, K., Yoshimoto, N., Suzumura, T., . . . Hirata, K. (2017). Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer. Intern Med.

Chicago Style Citation

Matsumoto, Yoshiya, et al. "Interstitial Lung Disease Induced By Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer." Intern Med 2017.

Cita MLA

Matsumoto, Yoshiya, et al. "Interstitial Lung Disease Induced By Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer." Intern Med 2017.